Biotech With 520% Sales Growth Nears Next Buy Point
Two Health Care Stocks Outperform S&P 500, Offer Entries
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
Ascendis Pharma A/S (ASND) Rose on Positive Trial Results
Buy Rating Affirmed for Ascendis Pharma Amid Favorable Market Dynamics and Strong TransCon PTH Outlook
Analysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), Conmed (CNMD) and Ascendis Pharma (ASND)
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
U.S. FDA declines to approve Ascendis' hormone disorder therapy
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.